Status

DEXamethasone twice for pain treatment of Total Knee Arthroplasty (DEX-2-TKA)

A randomized blinded placebo-controlled clinical trial

25-10-2019: Less than 100 patients to go

06-10-2019: 75% of all patients icluded.

01-10-2019: Zealand University Hospital Køge is stopping including patients

05-9-2019:66% og all patients included. Only one third to go.

03-09-2019: First patient at Gildhøj Private Hospital

14-08-2019: 60% of all patients included.

27-06-2019: DEX-2-TKA is cleared to start up at Gildhøj Private Hospital by GCP-unit

05-06-2019: 50% of all patients included.

29-04-2019: 40% of all patients included.

25-02-2019: 25% of all patients inculded.

14-01-2019: First patient at Zealand University Hospital Køge

20-12-2018: First patient at Odense University Hospital

07-12-2018: DEX-2-TKA is cleared to start up at Zealand University Hospital Køge by GCP-unit

30-10-2018: DEX-2-TKA is cleared to start up at Odense University Hospital by GCP-unit

08-10-2018: First patient at Næstved Hospital

02-10-2018: First patient at Bispebjerg Hosptial

24-09-2018: DEX-2-TKA is cleared to start up at Bispebjerg Hospital by GCP-unit

10-09-2018: DEX-2-TKA is cleared to start up at Næstved Hospital by GCP-unit

Mållinje 43-19
Site 43-19
Cake 43-19
Inclusion week 43-19

STATUS

Webmaster: Daniel Hägi-Pedersen

info@appraz.dk

Copyright © All Rights Reserved.